Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in TAYSHA GENE THERAPIES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 265,795 shares of TSHA (TAYSHA GENE THERAPIES INC), worth $1.2M as of 2026-Q1. The position was increased (+58.7% shares). TSHA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.2M
Current Shares
265,795
Total Value Change
+$266,854
Total Shares Change
+98,295
Other major holders of TSHA: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc., GOLDMAN SACHS GROUP INC
Increased |
| 265,795 |
+58.7% |
| $1.2M |
| 0.0% |
| $4.53 |
36 |
| 2025-Q4 | New | 167,500 | - | $921,250 | 0.0% | $5.66 | 35 |